New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published:November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like WIN Consortium revolutionizing precision oncology for cancer patients March 18, 2025 An Arm and a Leg: Wait, is Insulin cheaper now? February 28, 2024 INTEGRA’s innovative modules simplify magnetic bead purification workflows February 22, 2024